Murphy Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Murphy Capital Management's GILD Position: Q4 2020 in Review
Murphy Capital Management sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 3,614 shares — an estimated $228K sold.
Murphy Capital Management first reported a position in GILD in Q2 2013 and held it in 26 quarters. The position peaked at $1.94M in Q3 2014. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.
- Murphy Capital Management reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
- Murphy Capital Management sold 3,614 Gilead Sciences shares in Q4 2020, an estimated $228K.
- Murphy Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 26 quarters.
- Murphy Capital Management's Gilead Sciences position peaked at $1.94M in Q3 2014.
- 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.
Based on Murphy Capital Management's 13F filing for Q4 2020, filed 5 Feb 2021.